Richard C Pasternak Net Worth

The estimated Net Worth of Richard C Pasternak is at least $14.5 Thousand dollars as of 20 October 2022. Richard Pasternak owns over 10,000 units of Milestone Pharmaceuticals Inc stock worth over $14,500 and over the last 5 years Richard sold MIST stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Richard Pasternak MIST stock SEC Form 4 insiders trading

Richard has made over 1 trades of the Milestone Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Richard bought 10,000 units of MIST stock worth $52,000 on 20 October 2022.

The largest trade Richard's ever made was buying 10,000 units of Milestone Pharmaceuticals Inc stock on 20 October 2022 worth over $52,000. On average, Richard trades about 1,667 units every 0 days since 2019. As of 20 October 2022 Richard still owns at least 10,000 units of Milestone Pharmaceuticals Inc stock.

You can see the complete history of Richard Pasternak stock trades at the bottom of the page.

What's Richard Pasternak's mailing address?

Richard's mailing address filed with the SEC is C/O MILESTONE PHARMACEUTICALS INC., 1111 DR. FREDERIK-PHILIPS BLVD, STE 420, MONTREAL, A8, H4M 2X6.

Insiders trading at Milestone Pharmaceuticals Inc

Over the last 6 years, insiders at Milestone Pharmaceuticals Inc have traded over $8,160,062 worth of Milestone Pharmaceuticals Inc stock and bought 3,714,592 units worth $46,347,389 . The most active insiders traders include Holdings A/S Novo, Investments, Lpwong Roderic..., and Joseph C Papa. On average, Milestone Pharmaceuticals Inc executives and independent directors trade stock every 57 days with the average trade being worth of $438,690. The most recent stock trade was executed by David Bharucha on 1 December 2022, trading 10,000 units of MIST stock currently worth $47,400.

What does Milestone Pharmaceuticals Inc do?

milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.

Complete history of Richard Pasternak stock trades at Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc executives and stock owners

Milestone Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Joseph G. Oliveto,
  CEO, Pres & Director
• Amit Hasija,
  CFO & Exec. VP of Corp. Devel.
• Dr. Francis Plat,
  Chief Medical Officer
• Lorenz Muller,
  Chief Commercial Officer
• Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.,
  Chief Medical Advisor & Member of the Scientific Advisory Board
• Jeff Nelson,
  Chief Operating Officer
• Dr. Philippe Douville,
  Founder, Strategic Advisor & Member of Scientific Advisory Board
• Richard C Pasternak,
  Director
• Debra K. Liebert,
  Director
• Paul F Truex,
  Director
• Joseph C Papa,
  
• Amit Hasija,
  CFO & EVP of Corp. Development
• Seth H. Z. Fischer,
  
• Timothy Maness,
  Chief Accounting Officer
• Philippe Douville,
  Chief Scientific Officer
• De Solidarite Des Travaille...,
  10% owner
• Holdings A/S Novo,
  10% owner
• Investments, Lpwong Roderic...,
  
• Capital Inc. Bdc,
  10% owner
• Francis Plat,
  Chief Medical Officer
• Joseph Oliveto,
  President and CEO
• Lorenz Muller,
  Chief Commercial Officer
• Paul R Edick,
  Director
• Michael John Tomsicek,
  
• Stuart Duty,
  
• David Bharucha,
  Chief Medical Officer
• Jeffrey Edward Nelson,
  Chief Operating Officer
• Lisa M. Giles,
  
• Robert James Wills,